A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro

Although tight‐junctions (TJs) at the blood–brain barrier (BBB) are important to prevent non‐specific entry of compounds into the CNS, molecular mechanisms regulating TJ maintenance remain still unclear. The purpose of this study was therefore to identify molecules, which regulate occludin expression, derived from astrocytes and pericytes that ensheathe brain microvessels by using conditionally immortalized adult rat brain capillary endothelial (TR‐BBB13), type II astrocyte (TR‐AST4) and brain pericyte (TR‐PCT1) cell lines. Transfilter co‐culture with TR‐AST4 cells, and exposure to conditioned medium of TR‐AST4 cells (AST‐CM) or TR‐PCT1 cells (PCT‐CM) increased occludin mRNA in TR‐BBB13 cells. PCT‐CM‐induced occludin up‐regulation was significantly inhibited by an angiopoietin‐1‐neutralizing antibody, whereas the up‐regulation by AST‐CM was not. Immunoprecipitation and western blot analyses confirmed that multimeric angiopoietin‐1 is secreted from TR‐PCT1 cells, and induces occludin mRNA, acting through tyrosine phosphorylation of Tie‐2 in TR‐BBB13 cells. A fractionated AST‐CM study revealed that factors in the molecular weight range of 30–100 kDa led to occludin induction. Conversely, occludin mRNA was reduced by transforming growth factor β1, the mRNA of which was up‐regulated in TR‐AST4 cells following hypoxic treatment. In conclusion, in vitro BBB model studies revealed that the pericyte‐derived multimeric angiopoietin‐1/Tie‐2 pathway induces occludin expression.

[1]  T. Terasaki,et al.  Augmented Expression of the Tight Junction Protein Occludin in Brain Endothelial Cell Line TR-BBB by Rat Angiopoietin-1 Expressed in Baculovirus-Infected Sf Plus Insect Cells , 2002, Pharmaceutical Research.

[2]  D. Breimer,et al.  Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier , 2000, Pharmaceutical Research.

[3]  Emi Nakashima,et al.  New approaches to in vitro models of blood-brain barrier drug transport. , 2003, Drug discovery today.

[4]  T. Terasaki,et al.  Rat brain pericyte cell lines expressing β2‐adrenergic receptor, angiotensin II receptor type 1A, klotho, and CXCR4 mRNAs despite having endothelial cell markers , 2003, Journal of cellular physiology.

[5]  Hyun Seok Song,et al.  SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.

[6]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[7]  Arshag D Mooradian,et al.  Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) , 2003, Mechanisms of Ageing and Development.

[8]  Czeslaw Radziejewski,et al.  Moving across membranes , 2003, Nature Structural Biology.

[9]  D. Little,et al.  PI3K signaling is required for prostaglandin-induced mucosal recovery in ischemia-injured porcine ileum. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[10]  M Chopp,et al.  Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice , 2002, Neuroscience.

[11]  C. Auffray,et al.  Transforming growth factor-beta1-modulated cerebral gene expression. , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  N. Abbott,et al.  Astrocyte–endothelial interactions and blood–brain barrier permeability * , 2002 .

[13]  D. Davies,et al.  Blood–brain barrier breakdown in septic encephalopathy and brain tumours * , 2002, Journal of anatomy.

[14]  N. Abbott Astrocyte–endothelial interactions and blood–brain barrier permeability , 2002, Journal of anatomy.

[15]  M. Obinata,et al.  Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-β1 and β-glycerophosphate , 2002 .

[16]  A. Zernecke,et al.  JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.

[17]  M. Obinata,et al.  Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-beta1 and beta-glycerophosphate. , 2002, European journal of cell biology.

[18]  M. Obinata,et al.  Acidic amino acid transport characteristics of a newly developed conditionally immortalized rat type 2 astrocyte cell line (TR-AST). , 2001, Cell structure and function.

[19]  T. Acker,et al.  Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization , 2001, Mechanisms of Development.

[20]  R. Macdermott,et al.  Interleukin-2 Receptor β Subunit-dependent and -independent Regulation of Intestinal Epithelial Tight Junctions* , 2001, The Journal of Biological Chemistry.

[21]  R. Egleton,et al.  Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. , 2001, American journal of physiology. Heart and circulatory physiology.

[22]  T. Terasaki,et al.  Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. , 2001, Biological & pharmaceutical bulletin.

[23]  R. Borchardt,et al.  VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. , 2001, American journal of physiology. Heart and circulatory physiology.

[24]  S. Mandriota,et al.  Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. , 2000, The American journal of pathology.

[25]  M. Obinata,et al.  mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a New in vitro BBB Model for Drug Targeting , 2000, Journal of drug targeting.

[26]  G. Firestone,et al.  Requirement for Ras and Phosphatidylinositol 3-Kinase Signaling Uncouples the Glucocorticoid-induced Junctional Organization and Transepithelial Electrical Resistance in Mammary Tumor Cells* , 1999, The Journal of Biological Chemistry.

[27]  K. Stelwagen,et al.  Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells , 1999, Molecular and Cellular Endocrinology.

[28]  K. Alitalo,et al.  Identification of Tek/Tie2 Binding Partners , 1999, The Journal of Biological Chemistry.

[29]  William Lee,et al.  Angiopoietin-1 and -2 Coiled Coil Domains Mediate Distinct Homo-oligomerization Patterns, but Fibrinogen-like Domains Mediate Ligand Activity* , 1999, The Journal of Biological Chemistry.

[30]  M. Obinata,et al.  Establishment of SV40-tsA58 transgenic rats as a source of conditionally immortalized cell lines. , 1999, Experimental animals.

[31]  N. Copeland,et al.  Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Pardridge Blood-brain barrier biology and methodology. , 1999, Journal of neurovirology.

[33]  J. LaManna,et al.  Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. , 1998, Brain research. Molecular brain research.

[34]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[35]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[36]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[37]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[38]  M. Obinata Conditionally immortalized cell lines with differentiated functions established from temperature‐sensitive T‐antigen transgenic mice , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[39]  M. Verbeek,et al.  Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein , 1997 .

[40]  Hiroshi Yamamoto,et al.  Induction of various blood‐brain barrier properties in non‐neural endothelial cells by close apposition to co‐cultured astrocytes , 1997, Glia.

[41]  M. Verbeek,et al.  Rapid degeneration of cultured human brain pericytes by amyloid beta protein. , 1997, Journal of neurochemistry.

[42]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[43]  R. D. Lynch,et al.  Occludin is a functional component of the tight junction. , 1996, Journal of cell science.

[44]  N. Thompson,et al.  Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. , 1996, Brain research. Molecular brain research.

[45]  Y. Tsujimoto,et al.  Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. , 1996, Cancer research.

[46]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[47]  A. Peters,et al.  Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex , 1991, The Anatomical record.

[48]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[49]  R. Miller,et al.  Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .